The type of vascular access and the incidence of mortality in Japanese dialysis patients

Toshikazu Ozeki, Hideaki Shimizu, Yoshiro Fujita, Daijo Inaguma, Shoichi Maruyama, Yukako Ohyama, Shun Minatoguchi, Yukari Murai, Maho Terashita, Tomoki Tagaya

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objective The National Kidney Foundation (NKF) Kidney Disease Outcome Quality Initiative (KDOQI) guidelines have recommended the use of arteriovenous fistula (AVF) at the initiation of dialysis. However, there are significant differences in the dialysis environments of Japan and the United States, and there are few people who receive hemodialysis via a central venous catheter (CVC) in Japan. The aim of the present study was to examine the association between the type of vascular access at the initiation of dialysis and the incidence of mortality in Japan. Methods This study was a prospective, multicenter, cohort study. The data was collected by the Aichi Cohort study of Prognosis in Patients newly initiated into dialysis (AICOPP) in which 18 Japanese tertiary care centers participated. The present study enrolled 1,524 patients who were newly introduced to dialysis (the patients started maintenance dialysis between October 2011 and September 2013). After excluding 183 patients with missing data, 1,341 patients were enrolled. The Cox proportional hazards model was used to evaluate mortality based on the type of vascular access. The types of vascular access were divided into four categories: AVF, arteriovenous graft (AVG), CVC changed to AVF during the course (CAVF), CVC changed to AVG during the course (CAVG). Results A multivariate analysis revealed that AVG, CAVF and CAVG were associated with a higher risk of mortality in comparison to AVF [hazard ratio (HR), 1.60; p=0.048; HR, 2.26; p= 0.003; and HR, 2.45; p= 0.001, respectively]. Conclusion The research proved that the survival rate among patients in whom hemodialysis was initiated with AVF was significantly higher than that in patients in whom hemodialysis was initiated with AVG or CVC.

Original languageEnglish
Pages (from-to)481-485
Number of pages5
JournalInternal Medicine
Volume56
Issue number5
DOIs
Publication statusPublished - 01-01-2017

Fingerprint

Blood Vessels
Dialysis
Arteriovenous Fistula
Central Venous Catheters
Mortality
Incidence
Transplants
Renal Dialysis
Japan
Cohort Studies
Kidney Diseases
Proportional Hazards Models
Tertiary Care Centers
Multicenter Studies
Multivariate Analysis
Survival Rate
Maintenance
Guidelines
Kidney
Research

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Cite this

Ozeki, Toshikazu ; Shimizu, Hideaki ; Fujita, Yoshiro ; Inaguma, Daijo ; Maruyama, Shoichi ; Ohyama, Yukako ; Minatoguchi, Shun ; Murai, Yukari ; Terashita, Maho ; Tagaya, Tomoki. / The type of vascular access and the incidence of mortality in Japanese dialysis patients. In: Internal Medicine. 2017 ; Vol. 56, No. 5. pp. 481-485.
@article{7298d531fc9b41e1b6d75359f5807ba3,
title = "The type of vascular access and the incidence of mortality in Japanese dialysis patients",
abstract = "Objective The National Kidney Foundation (NKF) Kidney Disease Outcome Quality Initiative (KDOQI) guidelines have recommended the use of arteriovenous fistula (AVF) at the initiation of dialysis. However, there are significant differences in the dialysis environments of Japan and the United States, and there are few people who receive hemodialysis via a central venous catheter (CVC) in Japan. The aim of the present study was to examine the association between the type of vascular access at the initiation of dialysis and the incidence of mortality in Japan. Methods This study was a prospective, multicenter, cohort study. The data was collected by the Aichi Cohort study of Prognosis in Patients newly initiated into dialysis (AICOPP) in which 18 Japanese tertiary care centers participated. The present study enrolled 1,524 patients who were newly introduced to dialysis (the patients started maintenance dialysis between October 2011 and September 2013). After excluding 183 patients with missing data, 1,341 patients were enrolled. The Cox proportional hazards model was used to evaluate mortality based on the type of vascular access. The types of vascular access were divided into four categories: AVF, arteriovenous graft (AVG), CVC changed to AVF during the course (CAVF), CVC changed to AVG during the course (CAVG). Results A multivariate analysis revealed that AVG, CAVF and CAVG were associated with a higher risk of mortality in comparison to AVF [hazard ratio (HR), 1.60; p=0.048; HR, 2.26; p= 0.003; and HR, 2.45; p= 0.001, respectively]. Conclusion The research proved that the survival rate among patients in whom hemodialysis was initiated with AVF was significantly higher than that in patients in whom hemodialysis was initiated with AVG or CVC.",
author = "Toshikazu Ozeki and Hideaki Shimizu and Yoshiro Fujita and Daijo Inaguma and Shoichi Maruyama and Yukako Ohyama and Shun Minatoguchi and Yukari Murai and Maho Terashita and Tomoki Tagaya",
year = "2017",
month = "1",
day = "1",
doi = "10.2169/internalmedicine.56.7563",
language = "English",
volume = "56",
pages = "481--485",
journal = "Internal Medicine",
issn = "0918-2918",
publisher = "Japanese Society of Internal Medicine",
number = "5",

}

Ozeki, T, Shimizu, H, Fujita, Y, Inaguma, D, Maruyama, S, Ohyama, Y, Minatoguchi, S, Murai, Y, Terashita, M & Tagaya, T 2017, 'The type of vascular access and the incidence of mortality in Japanese dialysis patients', Internal Medicine, vol. 56, no. 5, pp. 481-485. https://doi.org/10.2169/internalmedicine.56.7563

The type of vascular access and the incidence of mortality in Japanese dialysis patients. / Ozeki, Toshikazu; Shimizu, Hideaki; Fujita, Yoshiro; Inaguma, Daijo; Maruyama, Shoichi; Ohyama, Yukako; Minatoguchi, Shun; Murai, Yukari; Terashita, Maho; Tagaya, Tomoki.

In: Internal Medicine, Vol. 56, No. 5, 01.01.2017, p. 481-485.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The type of vascular access and the incidence of mortality in Japanese dialysis patients

AU - Ozeki, Toshikazu

AU - Shimizu, Hideaki

AU - Fujita, Yoshiro

AU - Inaguma, Daijo

AU - Maruyama, Shoichi

AU - Ohyama, Yukako

AU - Minatoguchi, Shun

AU - Murai, Yukari

AU - Terashita, Maho

AU - Tagaya, Tomoki

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Objective The National Kidney Foundation (NKF) Kidney Disease Outcome Quality Initiative (KDOQI) guidelines have recommended the use of arteriovenous fistula (AVF) at the initiation of dialysis. However, there are significant differences in the dialysis environments of Japan and the United States, and there are few people who receive hemodialysis via a central venous catheter (CVC) in Japan. The aim of the present study was to examine the association between the type of vascular access at the initiation of dialysis and the incidence of mortality in Japan. Methods This study was a prospective, multicenter, cohort study. The data was collected by the Aichi Cohort study of Prognosis in Patients newly initiated into dialysis (AICOPP) in which 18 Japanese tertiary care centers participated. The present study enrolled 1,524 patients who were newly introduced to dialysis (the patients started maintenance dialysis between October 2011 and September 2013). After excluding 183 patients with missing data, 1,341 patients were enrolled. The Cox proportional hazards model was used to evaluate mortality based on the type of vascular access. The types of vascular access were divided into four categories: AVF, arteriovenous graft (AVG), CVC changed to AVF during the course (CAVF), CVC changed to AVG during the course (CAVG). Results A multivariate analysis revealed that AVG, CAVF and CAVG were associated with a higher risk of mortality in comparison to AVF [hazard ratio (HR), 1.60; p=0.048; HR, 2.26; p= 0.003; and HR, 2.45; p= 0.001, respectively]. Conclusion The research proved that the survival rate among patients in whom hemodialysis was initiated with AVF was significantly higher than that in patients in whom hemodialysis was initiated with AVG or CVC.

AB - Objective The National Kidney Foundation (NKF) Kidney Disease Outcome Quality Initiative (KDOQI) guidelines have recommended the use of arteriovenous fistula (AVF) at the initiation of dialysis. However, there are significant differences in the dialysis environments of Japan and the United States, and there are few people who receive hemodialysis via a central venous catheter (CVC) in Japan. The aim of the present study was to examine the association between the type of vascular access at the initiation of dialysis and the incidence of mortality in Japan. Methods This study was a prospective, multicenter, cohort study. The data was collected by the Aichi Cohort study of Prognosis in Patients newly initiated into dialysis (AICOPP) in which 18 Japanese tertiary care centers participated. The present study enrolled 1,524 patients who were newly introduced to dialysis (the patients started maintenance dialysis between October 2011 and September 2013). After excluding 183 patients with missing data, 1,341 patients were enrolled. The Cox proportional hazards model was used to evaluate mortality based on the type of vascular access. The types of vascular access were divided into four categories: AVF, arteriovenous graft (AVG), CVC changed to AVF during the course (CAVF), CVC changed to AVG during the course (CAVG). Results A multivariate analysis revealed that AVG, CAVF and CAVG were associated with a higher risk of mortality in comparison to AVF [hazard ratio (HR), 1.60; p=0.048; HR, 2.26; p= 0.003; and HR, 2.45; p= 0.001, respectively]. Conclusion The research proved that the survival rate among patients in whom hemodialysis was initiated with AVF was significantly higher than that in patients in whom hemodialysis was initiated with AVG or CVC.

UR - http://www.scopus.com/inward/record.url?scp=85014157650&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014157650&partnerID=8YFLogxK

U2 - 10.2169/internalmedicine.56.7563

DO - 10.2169/internalmedicine.56.7563

M3 - Article

C2 - 28250291

AN - SCOPUS:85014157650

VL - 56

SP - 481

EP - 485

JO - Internal Medicine

JF - Internal Medicine

SN - 0918-2918

IS - 5

ER -